Drug Trial Radar · NCT07667829
Vasopressor Agents in Pulmonary Hypertension Crisis
Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
75
Planned (sponsor's estimate)
Start
Aug 19, 2026
Primary completion
Dec 31, 2028
Study completion Jan 31, 2029
Sponsor
- Lead sponsor
- China National Center for Cardiovascular DiseasesGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Jun 25, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Comparison of the efficacy and safety of three vasoactive agents-dopamine, norepinephrine, and epinephrine-in the treatment of patients with pulmonary hypertension crisis: prospective, randomised controlled trial monitored by haemodynamic monitoring
Conditions
- Pulmonary Arterial Hypertension (PAH)
- Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
- Hypertension, Pulmonary
Interventions
NorepinephrineDrug
The initial dose is 0.02 mg/kg/min of norepinephrine; each dose adjustment (increase or decrease) is 0.02 mg/kg/min of norepinephrine; the maximum dose of norepinephrine is 0.2 mg/kg/min.
DopamineDrug
The initial dose is 2 μg/kg/min of dopamine; each dose adjustment (increase or decrease) is 2 μg/kg/min of dopamine; the maximum dose of dopamine is 20 μg/kg/min
EpinephrineDrug
The initial dose is 0.02 μg/kg/min of epinephrine; each adjustment (up or down) is 0.02 μg/kg/min of epinephrine; the maximum dose of epinephrine is 0.2 μg/kg/min
Primary outcomes
What the sponsor says the trial is designed to measure.
- All-cause mortality within 28 daysTime frame: 28 days after enrolment
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Chinese Academy of Medical Sciences, Fuwai Hospital
Beijing, Beijing Municipality, China · Recruiting
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China · Not yet recruiting
Zhongnan Hospital of Wuhan University
Wuhan, Wuhan, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.